C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 307/58 (2006.01) A61K 31/34 (2006.01) C07C 317/14 (2006.01) C07C 317/24 (2006.01) C07D 405/06 (2006.01)
Patent
CA 2285567
The invention encompasses the novel compound of Formula (I) as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula (I).
L'invention concerne un nouveau composé de formule (I) et un procédé de traitement des maladies induites par COX-2 consistant à administrer à un patient une quantité non toxique thérapeutiquement efficace d'un composé de formule (I). L'invention concerne aussi certaines compositions pharmaceutiques destinées au traitement de maladies induites par COX-2 comprenant des composés de formule (I).
Grimm Erich
Leger Serge
Prasit Petpiboon
Merck Frosst Canada & Co.
Merck Frosst Canada & Co./merck Frosst Canada & Cie
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Alpha-methylene gamma lactones as selective cyclooxygenase-2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-methylene gamma lactones as selective cyclooxygenase-2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-methylene gamma lactones as selective cyclooxygenase-2... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1997587